This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Jun 16;379(9833):2220-1.

doi: 10.1016/S0140-6736(12)60780-6. Epub 2012 Jun 9.

Choosing a blood-glucose-lowering agent after metformin

Michaela Diamant¹

Affiliations

PMID: 22683135
DOI: 10.1016/S0140-6736(12)60780-6

Comment

Choosing a blood-glucose-lowering agent after metformin

Michaela Diamant. Lancet. 2012.

. 2012 Jun 16;379(9833):2220-1.

doi: 10.1016/S0140-6736(12)60780-6. Epub 2012 Jun 9.

Author

Michaela Diamant¹

Affiliation

¹ Diabetes Centre, VU University Medical Centre, 1081 HV Amsterdam, The Netherlands. m.diamant@vumc.nl

PMID: 22683135
DOI: 10.1016/S0140-6736(12)60780-6

No abstract available

PubMed Disclaimer

Comment on

Insulin glargine versus sitagliptin in insulin-naive patients with type 2 diabetes mellitus uncontrolled on metformin (EASIE): a multicentre, randomised open-label trial.
Aschner P, Chan J, Owens DR, Picard S, Wang E, Dain MP, Pilorget V, Echtay A, Fonseca V; EASIE investigators. Aschner P, et al. Lancet. 2012 Jun 16;379(9833):2262-9. doi: 10.1016/S0140-6736(12)60439-5. Epub 2012 Jun 9. Lancet. 2012. PMID: 22683131 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information